In a filing, Castle Biosciences Inc revealed its Pres. & Chief Exec. Officer MAETZOLD DEREK J unloaded Company’s shares for reported $20380.0 on Dec 17 ’25. In the deal valued at $40.04 per share,509 shares were sold. As a result of this transaction, MAETZOLD DEREK J now holds 34,360 shares worth roughly $1.42 million.
Then, Oelschlager Kristen M sold 14,888 shares, generating $585,292 in total proceeds. Upon selling the shares at $39.31, the Chief Operating Officer now owns 12,323 shares.
Before that, Kristen M. Oelschlager bought 14,888 shares. Castle Biosciences Inc shares valued at $581,376 were divested by the Officer at a price of $39.05 per share.
Guggenheim initiated its Castle Biosciences Inc [CSTL] rating to a Buy in a research note published on December 14, 2023; the price target was $25. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Stephens began covering CSTL with “an Overweight” recommendation on January 07, 2022. Lake Street started covering the stock on April 30, 2021. It rated CSTL as “a Buy”.
Price Performance Review of CSTL
On Monday, Castle Biosciences Inc [NASDAQ:CSTL] saw its stock jump 4.94% to $41.39. Over the last five days, the stock has gained 6.46%. Castle Biosciences Inc shares have risen nearly 56.07% since the year began. Nevertheless, the stocks have risen 55.31% over the past one year. While a 52-week high of $40.61 was reached on 12/22/25, a 52-week low of $14.59 was recorded on 08/04/25.
Levels Of Support And Resistance For CSTL Stock
The 24-hour chart illustrates a support level at 40.13, which if violated will result in even more drops to 38.87. On the upside, there is a resistance level at 42.41. A further resistance level may holdings at 43.44.
How much short interest is there in Castle Biosciences Inc?
A steep rise in short interest was recorded in Castle Biosciences Inc stocks on 2025-11-28, growing by 0.29 million shares to a total of 1.84 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 1.55 million shares. There was a rise of 15.7%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
